Clinical Trials Logo

Grade 3/4 Neutropenia clinical trials

View clinical trials related to Grade 3/4 Neutropenia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02005783 Completed - Febrile Neutropenia Clinical Trials

Study of Danggui Buxue Decoction in Preventing Neutropenia

DIPE
Start date: October 2013
Phase: Phase 2
Study type: Interventional

To evaluate EC/TC (epirubicin and cyclophosphomide or docetaxel and cyclophosphomide) with EC/TC plus DBD (Danggui Buxue Decoction) in adjuvant treatment of breast cancer patients. The aim is to evaluate whether DBD can decrease the incidence of grade 3/4 neutropenia induced by EC/TC regimen during chemotherapy.